FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Previous studies provide a strong theoretical rationale for the conduct of a randomized study evaluating the efficacy and safety of Herceptin and pertuzumab in combination with FLOT in the perioperative treatment of resectable HER-2 positive adenocarcinoma of the stomach or GEJ.
Epistemonikos ID: 8adce75c8a60aa203eaba8cb9810acf2c04834e8
First added on: May 12, 2024